Sorbus Advisors LLC

About
Services
Professionals
Resources
Blog
Contact

BioPharmaceutical Valuations in Purchase Accounting

November 20, 2015 | by Max Fonarev

Recent Posts

Covid-19 | Valuation Update | Three Months In
COVID-19 | Valuation Update
Valuing VC Investments – An Intuitive Example
Valuation Market Multiples: Not So Simple
Purchase Price Allocation (ASC 805) Benchmarking Study IT 2018

Labels

Intangible Asset Valuation ASC 805 Purchase Accounting Business Interests Fair Value Term Sheet Portfolio Valuation Fair Market Value Tax Compliance IP Valuation Purchase Accounting Financial Reporting Financial Instruments Tax Valuation 409A Valuation Transactions Purchase Price Allocation Life Sciences ASC 805

Twitter
Linkedin

© 2021 Sorbus Advisors LLC. All Rights Reserved. | Terms of Use | Privacy Policy

Please leave your email address below to view this publication. By doing so, you consent to receive our quarterly newsletters. You can unsubscribe at any time.

First Name*
Last Name*
Company
Newsletter Sign up*